Kura Oncology (KURA) Cash from Operations (2023 - 2026)

Kura Oncology has reported Cash from Operations over the past 4 years, most recently at 85854000.0 for Q1 2026.

  • Quarterly Cash from Operations fell 19.36% to 85854000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 77985000.0 through Mar 2026, down 170.11% year-over-year, with the annual reading at 64058000.0 for FY2025, 147.69% down from the prior year.
  • Cash from Operations was 85854000.0 for Q1 2026 at Kura Oncology, down from 117273000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 269131000.0 in Q4 2024 and troughed at 85854000.0 in Q1 2026.
  • The 4-year median for Cash from Operations is 35872000.0 (2023), against an average of 10801461.54.
  • Year-over-year, Cash from Operations skyrocketed 884.46% in 2024 and then crashed 85.61% in 2025.
  • A 4-year view of Cash from Operations shows it stood at 34308000.0 in 2023, then skyrocketed by 884.46% to 269131000.0 in 2024, then crashed by 56.43% to 117273000.0 in 2025, then crashed by 173.21% to 85854000.0 in 2026.
  • Per Business Quant, the three most recent readings for KURA's Cash from Operations are 85854000.0 (Q1 2026), 117273000.0 (Q4 2025), and 80627000.0 (Q3 2025).